Integrated Safety Analysis of Ritlecitinib in Adolescent Patients with Alopecia Areata from the Randomized, Placebo-Controlled ALLEGRO Phase 2b/3 and Ongoing Open-Label Phase 3 ALLEGRO-LT Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s294, 2023. DOI: 10.25251/skin.7.supp.294. Disponível em: https://skin.dermsquared.com/skin/article/view/2377. Acesso em: 17 may. 2025.